Learn about Sclerosing Hemangioma Treatment in Turkey — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in Sclerosing Hemangioma and request assistance for cost estimates or appointments.

About Sclerosing Hemangioma

Sclerosing hemangioma treatment is a specialized dermatological procedure used to manage a benign vascular skin lesion known as a sclerosing hemangioma or dermatofibroma. This minimally invasive technique involves the injection of a sclerosing agent directly into the lesion. The solution causes the targeted blood vessels to collapse, scar, and eventually be reabsorbed by the body, leading to a significant flattening and lightening of the raised, reddish-brown nodule. Performed by a dermatologist in an outpatient clinic setting, this procedure is valued for its precision, minimal discomfort, and excellent cosmetic outcomes, offering a non-surgical alternative to excision for suitable lesions.

Key Highlights

    Minimally invasive, non-surgical procedure performed in-office.Targeted treatment that spares surrounding healthy skin.Typically requires only local anesthesia for comfort.Minimal to no scarring compared to surgical excision.Short procedure time, often completed in under 30 minutes.Effective for flattening and reducing the color of the lesion./ul

Who is this surgery for?

  • Diagnosed benign sclerosing hemangioma (dermatofibroma).
  • Lesions that are cosmetically bothersome to the patient.
  • Growths that are prone to irritation from clothing or friction.
  • Lesions that have changed in appearance, requiring therapeutic intervention after biopsy confirmation.
  • Patient preference for a non-excisional treatment option.

How to prepare

  • Consultation with a dermatologist for diagnosis and treatment planning.
  • Disclosure of all medications, especially blood thinners, to the doctor.
  • Avoidance of anti-inflammatory drugs (like aspirin or ibuprofen) as advised, to minimize bruising.
  • Cleansing the skin area with mild soap prior to the appointment.
  • No specific fasting is required for this local procedure.

Risks & possible complications

  • Temporary pain, swelling, or bruising at the injection site.
  • Possible skin ulceration or necrosis if the sclerosing agent affects surrounding tissue.
  • Risk of infection, though minimal with proper sterile technique.
  • Changes in skin pigmentation (hyperpigmentation or hypopigmentation).
  • Incomplete resolution, potentially requiring additional treatment sessions.
  • Allergic reaction to the sclerosing agent (rare).

Recovery & hospital stay

  • Mild tenderness and swelling are common for 24-48 hours; apply a cold compress if needed.
  • Keep the area clean and dry as per the dermatologist's instructions.
  • Avoid strenuous exercise, swimming, or soaking the area for 2-3 days.
  • The lesion will gradually darken, form a scab, and flatten over several weeks.
  • Attend any scheduled follow-up appointments to monitor healing and assess results.
  • Use sunscreen on the treated area once healed to protect new skin and prevent pigmentation changes.
  • checked Typical hospital stay: 0 days (outpatient procedure)
  • checked Expected recovery time: 1-2 weeks for initial healing; final results visible over 4-8 weeks

Frequently Asked Questions

If you are considering sclerosing hemangioma in Turkey, these questions and answers can help you make a confident, informed decision.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for sclerosing hemangioma compare across other countries where we have data.

Country Estimated cost range Typical stay Recovery time View details
India USD 33 – USD 88 0 days (outpatient procedure) ~ 1-2 weeks for initial healing; final results visible over 4-8 weeks Know More
Turkey USD 246 – USD 656 0 days (outpatient procedure) ~ 1-2 weeks for initial healing; final results visible over 4-8 weeks Know More
PATIENT REVIEW

Reyansh Saxena, a 28-year-old software engineer,...

Reyansh Saxena, a 28-year-old software engineer, first noticed a small, painless red bump on his left cheek during his morning shave about a year ago. Initially dismissing it as a stubborn pimple, he grew concerned as it slowly but steadily grew larger and became more raised, taking on a darker, cherry-red color. It would occasionally bleed with minimal trauma, like when he dried his face with a towel. This was particularly distressing for Reyansh, who was preparing for a series of important client-facing presentations at work. His dermatologist, Dr. Sharma, examined the lesion and diagnosed it as a sclerosing hemangioma, a benign but cosmetically bothersome blood vessel growth. She explained that while harmless, it would likely continue to grow and bleed, and recommended sclerotherapy, injecting a solution directly into it to collapse the abnormal vessels. During the brief in-office procedure, Reyansh felt a few sharp pinpricks and a mild burning sensation as the solution was injected. The area became swollen and bruised for about a week. Over the next month, the lesion flattened significantly and faded to a light pink mark. Emotionally, Reyansh moved from self-conscious anxiety, constantly worrying others were staring at his face, to immense relief. The successful treatment restored his confidence for his professional engagements, and he was grateful for a simple solution to a problem that had weighed on him more than he'd admitted.